Who’s Developing What in Drug Delivery?

Pharma Business Daily
Claim your FREE trial subscription!

Pharmaceutical:

Who’s Developing What in Drug Delivery?

Espicom Business Intelligence
Market Briefing October 2007

Understand the structure, performance, R&D and products of over 100 leading drug delivery companies

The importance of drug delivery technology grows ever greater and commercial and industry interest continues to build steadily. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to bring new products to market and extend patent protection through novel delivery regimes and bring new therapies to the market that would, previously, have been impossible.

The drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have seen significant attention from customers and investors alike, and merger and acquisition activity is notable. Who’s Developing What in Drug Delivery? is a new management report (3rd edition published October 2007) that provides comprehensive analysis of 105 leading players in the drug delivery field. Important areas covered for each company analysed include:
Company Overview & technology focus
Key Personnel
Key Milestones
Competition & Competing Products Products/Technologies
R&D & Research Strategy
Key Agreements & Alliances
Financial Data
Comprehensive Contact Details

Focus on leading companies in the field
3M DDS
Access Pharmaceuticals
Acusphere
Acrux
Akela Pharma
Alizyme
Alkermes
AlphaRx
AlphaVax
Altea Therapeutics
ALZA Corporation
Antares Pharma
AP Pharma
Aradigm Corporation
Baxa Corporation
Baxter International
Bentley Pharmaceuticals
Bespak
BioDelivery Sciences International
Bioject Medical Technologies
BioSante Pharmaceuticals
Biovail Corporation
Bradley Pharmaceuticals
Camurus AB
Cardinal Health
Cephalon
Cipher Pharmaceuticals Columbia Laboratories
Critical Therapeutics
CyDex
DebioPharm
Delcath Systems
Delsite Biotechnologies
DepoMed
Diatos
DOR Biopharma
Durect Corporation
DUSA Pharmaceuticals
Echo Therapeutics
Eiffel Technologies
Elite Pharmaceticals
Emisphere Technologies
Encap Drug Delivery
Endo Pharmaceuticals
Endovasc
Enzon
Ethypharm
Eurand
Expression Genetics
Fertin Pharma
Flamel Technologies
Fziomed
Generex Biotechnology Corporation
Hospira Impax Laboratories
Indevus Pharmaceuticals
Innocoll Technologies
Inovio Biomedical
InSite Vision
Intranasal Therapeutics
Iomai Corporation
KV Pharmaceutical
Labopharm
Light Sciences Corporation
MacroChem Corporation
MaxCyte
MedImmune
Meldex International
Milestone Scientific
Moog Medical Devices
Nanotherapeutics
Nastech Pharmaceutical Company
Nektar Therapeutics
Neurotech
NexMed
Norwood Abbey
NovaDel Pharma
Novagali Pharma
Novavax
Noven Pharmaceuticals
Oakwood Laboratories OctoPlus
Orexo
Oriel Therapeutics
Otsuka
Penwest Pharmaceuticals
Phoqus Group
Phosphagenics Ltd
PhotoCure
pSivida
QLT
Respironics
Scolr Pharma
Skinvisible
SkyePharma
Sonus Pharmaceuticals
Spherics
Syntonix Pharmaceuticals
Tekmira Pharmaceuticals
TransPharma Medical
Urigen Pharmaceuticals
Vectura
Ventaira Pharmaceuticals
Vivus
Zogenix

Number of pages - 201

For full details, please email keithw@cmsinfo.com

Order Form

CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: Jennifer Cowlard

For more information about us, visit CMSinfo.